Proteinase K Market

Proteinase K Market, By Form (Lyophilized Powder Form, Liquid Form), By Application (Purification of DNA & RNA, In situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End User (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Proteinase K (also known as protease K or endopeptidase K) is a broad-spectrum serine protease widely used in molecular biology. Proteinase K can digest native keratin (hair), hence, the name “Proteinase K”. It is commonly used because of its broad specificity, which makes it useful to clean nucleic acid complexes and to lyse cells. It has been used for the isolation of mRNA, and high-molecular-weight DNA and to inactivate other enzymatic activities. The enzyme was discovered in 1974 in extracts of the fungus Engyodontium album (formerly Tritirachium album). Proteinase K is commonly used in molecular biology to digest proteins and remove contamination from preparations of nucleic acid. The addition of proteinase K to nucleic acid preparations rapidly inactivates nucleases that might otherwise degrade the DNA or RNA during purification, hence ideal for these applications. Proteinase K is a cation. It is highly suited to this application since the enzyme is active in the presence of chemicals that denature proteins, such as sodium dodecyl sulphate and urea, chelating agents such as EDTA, sulfhydryl reagents, as well as trypsin or chymotrypsin inhibitors. Proteinase K is used for the destruction of proteins in cell lysates (tissue, cell culture cells) and the release of nucleic acids.

Market Dynamics

In order to accelerate and broaden the development program and to further diversify the company’s portfolio, the key market players are focusing on the adoption of growth strategies such as applications of the proteinase K enzyme in novel diagnostic kits which is attributed to the growth of the global Proteinase K market. For instance, according to an article published in the Journal Med, on December 25, 2020, Proteinase K has the potential to work as an affordable, fast, and easy alternative to nucleic acid extraction with only a minor loss of sensitivity. Hence, it was used in SalivaDirect, an alternative diagnostic procedure for COVID-19 that uses saliva instead of nasopharyngeal swabs.

Key features of the study:

This report provides an in-depth analysis of the global Proteinase K market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Proteinase K market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., F. Hoffmann-La Roche Ltd, New England Biolabs. Worthington Biochemical Corporation, Norgen Biotek Corp., Bioron GmbH, Sisco Research Laboratories Pvt. Ltd., Bioline (Meridian Biosciences Inc.), Promega Corporation.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global Proteinase K Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global proteinase K market

Detailed Segmentation:

Global Proteinase K Market, By Form:

Lyophilized Powder Form

Liquid Form

Global Proteinase K Market, By Application:

Purificaion of DNA & RNA

In situ Hybridization

Mitochondria Isolation

Enzyme Removal

Global Proteinase K Market, By End User:

Contract Research Organization

Academic Institutes

Biotechnology Companies

Diagnosis Laboratories

Global Proteinase K Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country/Region:

South Africa

Central Africa

North Africa

Company Profiles

Thermo Fisher Scientific Inc.*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Merck KGaA

Qiagen N.V.

F.Hoffmann-La Roche Ltd.

New England Biolabs

Worthington Biochemical Corporation

Norgen Biotek Corp.

BIORON GmbH

Sisco Research Laboratories Pvt. Ltd.

Bioline (Meridian Biosciences Inc.)

Promega Corporation

“*” marked represents similar segmentation in other categories in the respective section.